Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Fourteen Year Study Concludes: Anthocyanins Lower Hypertension Risk

By LabMedica International staff writers
Posted on 27 Jan 2011
Anthocyanins, obtained primarily from blueberries and strawberries, reduce the risk of developing hypertension and join the list of flavonoids present in tea, fruit juice, red wine, and dark chocolate as food products that protect against cardiovascular disease.

Investigators at the University of East Anglia (Norwich, United Kingdom) and the Harvard School of Public Health (Boston, MA, USA) followed the eating habits of more than 134,000 women and 47,000 men to examine the relationship between flavonoids and development of hypertension. More...
The subjects, none of whom suffered from hypertension at the beginning of the study, were monitored for 14 years. During this period, they completed health questionnaires every two years, and their dietary intake was assessed every four years.

Results published in the November 24, 2010, online edition of the American Journal of Clinical Nutrition revealed that 29,018 women and 5629 men developed hypertension over the 14-year study period. Evaluation of their dietary questionnaires showed that tea was the main contributor of flavonoids, with apples, orange juice, blueberries, red wine, and strawberries also providing important amounts. Further analysis revealed that subjects consuming the highest amounts of anthocyanins (found mainly in blueberries and strawberries) were 8% less likely to be diagnosed with hypertension than those consuming the lowest amounts. Blueberries were the most potent source of anthocyanins, and those eating at least one serving of blueberries per week were 10% less likely to become hypertensive than those eating no blueberries.

"Our findings are exciting and suggest that an achievable dietary intake of anthocyanins may contribute to the prevention of hypertension,” said first author Dr. Aedin Cassidy, professor of nutrition at the University of East Anglia. "Anthocyanins are readily incorporated into the diet as they are present in many commonly consumed foods. Blueberries were the richest source in this particular study as they are frequently consumed in the United States. Other rich sources of anthocyanins in the United Kingdom include blackcurrants, blood oranges, aubergines [eggplant], and raspberries.”

Related Links:
University of East Anglia
Harvard School of Public Health


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Alcohol Testing Device
Dräger Alcotest 7000
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.